公开(公告)号：US09833423B2

公开(公告)日：2017-12-05

申请号：US15098972

申请日：2016-04-14

申请人： KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY ,  KATHOLIEKE UNIVERSITEIT LEUVEN K.U. LEUVEN R & D

发明人： Young Sik Jung ,  Chong Kgo Lee ,  Ihl Young Choi ,  Hae Soo Kim ,  Phil Ho Kim ,  Soo Bong Han ,  Johan Neyts ,  Hendrik Jan Thibaut

IPC分类号： A61K31/122 ,  A61K31/435 ,  C07D221/04 ,  C07C49/747 ,  C07C271/24 ,  C07C271/44 ,  C07C271/64 ,  C07C275/26 ,  C07C275/64 ,  C07C205/45 ,  C07C323/22 ,  C07C225/20 ,  C07C225/22 ,  C07C233/32 ,  C07C233/33 ,  C07C233/41 ,  C07C233/43 ,  C07C233/61 ,  C07C233/76 ,  C07C247/14 ,  C07C69/16 ,  C07C69/18 ,  C07C69/28 ,  C07C69/54 ,  C07C69/618 ,  C07C69/63 ,  C07C69/738 ,  C07C69/78 ,  C07C49/753 ,  C07D215/20 ,  C07D213/65 ,  C07C45/00 ,  C07C67/00 ,  C07C69/12 ,  C07C69/22 ,  C07C69/736 ,  C07C269/00 ,  C07C49/755 ,  C07C67/08 ,  C07C231/02 ,  C07C271/12

CPC分类号： A61K31/122 ,  A61K31/435 ,  C07C45/00 ,  C07C49/747 ,  C07C49/753 ,  C07C49/755 ,  C07C67/00 ,  C07C67/08 ,  C07C69/12 ,  C07C69/16 ,  C07C69/18 ,  C07C69/22 ,  C07C69/28 ,  C07C69/54 ,  C07C69/618 ,  C07C69/63 ,  C07C69/736 ,  C07C69/738 ,  C07C69/78 ,  C07C205/45 ,  C07C225/20 ,  C07C225/22 ,  C07C231/02 ,  C07C233/32 ,  C07C233/33 ,  C07C233/41 ,  C07C233/43 ,  C07C233/61 ,  C07C233/76 ,  C07C247/14 ,  C07C269/00 ,  C07C271/12 ,  C07C271/24 ,  C07C271/44 ,  C07C271/64 ,  C07C275/26 ,  C07C275/64 ,  C07C323/22 ,  C07C2601/02 ,  C07C2602/08 ,  C07D213/65 ,  C07D215/20 ,  C07D221/04

摘要： Disclosed are 1,3-Dioxoindene derivatives, pharmaceutically acceptable salts thereof or enantiomers, a preparation method thereof, and a pharmaceutical composition for the prevention or treatment of viral diseases, comprising the same as an active ingredient. The 1,3-Dioxoindene derivatives have excellent inhibitory activity against picornaviruses including coxsackie-, entero-, echo-, Polio-, and rhinoviruses, as well as exhibiting low cytotoxicity, so that they can be useful as an active ingredient of a pharmaceutical composition for the prevention or treatment of viral diseases including poliomyelitis, paralysis, acute hemorrhagic conjunctivitis, viral meningitis, hand-foot-and-mouth disease, vesicular disease, hepatitis A, myositis, myocarditis, pancreatitis, diabetes, epidemic myalgia, encephalitis, cold, herpangina, foot-and-mouth disease, asthma, chronic obstructive pulmonary disease, pneumonia, sinusitis or otitis media.